Needham Investment Management LLC Increases Holdings in Aspen Aerogels, Inc. $ASPN

Needham Investment Management LLC increased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 26.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,351,700 shares of the construction company’s stock after buying an additional 912,000 shares during the quarter. Needham Investment Management LLC owned about 5.27% of Aspen Aerogels worth $12,315,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in ASPN. Invesco Ltd. lifted its position in Aspen Aerogels by 1,045.5% during the second quarter. Invesco Ltd. now owns 831,991 shares of the construction company’s stock worth $4,925,000 after buying an additional 759,360 shares in the last quarter. JPMorgan Chase & Co. raised its position in Aspen Aerogels by 105.4% in the second quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock valued at $7,379,000 after purchasing an additional 639,753 shares during the period. Goldman Sachs Group Inc. raised its position in Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock valued at $8,143,000 after purchasing an additional 602,586 shares during the period. State Street Corp raised its position in Aspen Aerogels by 28.6% in the fourth quarter. State Street Corp now owns 2,501,469 shares of the construction company’s stock valued at $7,079,000 after purchasing an additional 556,833 shares during the period. Finally, Millennium Management LLC raised its position in Aspen Aerogels by 59.6% in the third quarter. Millennium Management LLC now owns 1,447,517 shares of the construction company’s stock valued at $10,075,000 after purchasing an additional 540,772 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Trading Up 1.9%

Shares of NYSE ASPN opened at $6.03 on Tuesday. Aspen Aerogels, Inc. has a twelve month low of $2.30 and a twelve month high of $9.78. The company has a current ratio of 2.89, a quick ratio of 2.54 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $4.76 and a 200-day simple moving average of $3.82. The stock has a market capitalization of $500.10 million, a PE ratio of -4.44 and a beta of 3.02.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The firm had revenue of $37.88 million during the quarter, compared to analyst estimates of $36.58 million. During the same period in the previous year, the firm posted ($0.06) earnings per share. The company’s quarterly revenue was down 51.8% compared to the same quarter last year. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. On average, equities analysts forecast that Aspen Aerogels, Inc. will post -0.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on ASPN. TD Cowen reduced their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Wall Street Zen upgraded Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Roth Mkm restated a “buy” rating and issued a $5.75 target price on shares of Aspen Aerogels in a research report on Friday, May 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Friday, March 27th. Finally, Barclays lifted their target price on Aspen Aerogels from $3.00 to $4.00 and gave the company an “underweight” rating in a research report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $5.19.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.